• Home
  • About Us
    • Company History
    • Direction
    • The Team
  • Products
  • News
  • Partners
    • Partnering
    • Existing Partners
  • Distribution
  • Contact

Max Health

  • Home
  • About Us
    • Company History
    • Direction
    • The Team
  • Products
  • News
  • Partners
    • Partnering
    • Existing Partners
  • Distribution
  • Contact
NewsWeb.jpg

News


New Zealand Pharmacy Technicians Special Interest Group Meeting – Saturday 15th March

February 12, 2014

Max Health™ is delighted to be sponsoring the Pharmacy Technicians Special Interest Meeting

NZHPA Max Health™ Pharmacy Grant Winner Announced

October 17, 2013

The NZHPA Max Health™ Pharmacy Grant for 2013 has been awarded to Avril Lee

Approval of Glycopyrronium 0.5mg/ml and Neostigmine 2.5mg/ml injection

July 18, 2013

Max Health™ has just been advised by Medsafe that, effective 11 July 2013 the combination injection of Glycopyrronium and Neostigmine (from Martindale) has been registered.

Glycopyrronium bromide injection – Sole Supply Listing - Section H

July 4, 2013

Max Health™ has been awarded Hospital Supply Status for Glycopyrronium bromide Injection...

Magnesium Sulphate injection - New Tender Listing - Section H and Section B

November 16, 2012

Max Health™ has been awarded Hospital Supply Status for Magnesium Sulphate Injection...

Oxycodone Injection- New Sole Supply and Hospital Supply information

September 21, 2012

Max Health™ has been awarded Sole Supply and Hospital Supply Status...

Newer
Older
Top

© Max Health™ Limited 2017